Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hepatitis B Virus Vaccines
Research from W.M. Xu and co-researchers in the area of hepatitis B virus vaccines published
February 18th, 2009
Research findings, 'Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study,' are discussed in a new report. According to recent research from Shanghai, People's Republic of China, "This randomized, double-blind, placebo-controlled study evaluated whether lamivudine given during late pregnancy can reduce hepatitis B virus (HBV) perinatal transmission in highly viraemic mothers. Mothers were randomized to either lamivudine 100 mg or placebo from week 32 of gestation to week 4 postpartum." "At birth, infants received recombinant HBV vaccine with or without HBIg and...
Source: Vaccine Weekly (2009-02-18)
|
